Literature DB >> 2654844

Malignant melanoma. A multivariate analysis of prognostic factors.

R T Vollmer.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2654844

Source DB:  PubMed          Journal:  Pathol Annu        ISSN： 0079-0184


× No keyword cloud information.
  13 in total

1.  Progressive increase in telomerase activity from benign melanocytic conditions to malignant melanoma.

Authors:  R D Ramirez; S D'Atri; E Pagani; T Faraggiana; P M Lacal; R S Taylor; J W Shay
Journal:  Neoplasia       Date:  1999-04       Impact factor: 5.715

2.  Histological ulceration as a prognostic factor in cutaneous melanoma: a study of 423 cases in Spain.

Authors:  José Antonio Avilés-Izquierdo; Pablo Lázaro-Ochaita
Journal:  Clin Transl Oncol       Date:  2012-03       Impact factor: 3.405

3.  The prognostic significance of microsatellites in cutaneous melanoma.

Authors:  Maarten G Niebling; Lauren E Haydu; Serigne N Lo; Robert V Rawson; Lieke G E Lamboo; Joram T Stollman; Rooshdiya Z Karim; John F Thompson; Richard A Scolyer
Journal:  Mod Pathol       Date:  2020-02-13       Impact factor: 7.842

Review 4.  Staging and prognosis of cutaneous melanoma.

Authors:  Paxton V Dickson; Jeffrey E Gershenwald
Journal:  Surg Oncol Clin N Am       Date:  2011-01       Impact factor: 3.495

Review 5.  Management of the regional lymph nodes in patients with cutaneous malignant melanoma.

Authors:  A J Cochran; D R Wen; D L Morton
Journal:  World J Surg       Date:  1992 Mar-Apr       Impact factor: 3.352

6.  Reduced level of CD44 and hyaluronan associated with unfavorable prognosis in clinical stage I cutaneous melanoma.

Authors:  J M Karjalainen; R H Tammi; M I Tammi; M J Eskelinen; U M Agren; J J Parkkinen; E M Alhava; V M Kosma
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

7.  ACP best practice no 162. The histological reporting of melanoma. Association of Clinical Pathologists.

Authors:  E Calonje
Journal:  J Clin Pathol       Date:  2000-08       Impact factor: 3.411

Review 8.  The changing prognosis of melanoma.

Authors:  A C Buzaid; C M Anderson
Journal:  Curr Oncol Rep       Date:  2000-07       Impact factor: 5.075

9.  Clinicopathological Features, Staging, and Current Approaches to Treatment in High-Risk Resectable Melanoma.

Authors:  Emily Z Keung; Jeffrey E Gershenwald
Journal:  J Natl Cancer Inst       Date:  2020-09-01       Impact factor: 13.506

10.  Treatment and outcomes of melanoma in acral location in Korean patients.

Authors:  Mi Ryung Roh; Jihyun Kim; Kee Yang Chung
Journal:  Yonsei Med J       Date:  2010-07       Impact factor: 2.759
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.